6-Butyramido-N-methyl-4-((2-(methylsulfonyl)phenyl)amino)nicotinamide

ID: ALA4542289

Chembl Id: CHEMBL4542289

PubChem CID: 155551442

Max Phase: Preclinical

Molecular Formula: C18H22N4O4S

Molecular Weight: 390.47

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC(=O)Nc1cc(Nc2ccccc2S(C)(=O)=O)c(C(=O)NC)cn1

Standard InChI:  InChI=1S/C18H22N4O4S/c1-4-7-17(23)22-16-10-14(12(11-20-16)18(24)19-2)21-13-8-5-6-9-15(13)27(3,25)26/h5-6,8-11H,4,7H2,1-3H3,(H,19,24)(H2,20,21,22,23)

Standard InChI Key:  FQHIMHYWSNDPOL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4542289

    ---

Associated Targets(Human)

JAK2 Tclin JAK2/TYK2 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin JAK1/TYK2 (259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYK2 Tclin Tyrosine-protein kinase TYK2 (5029 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.47Molecular Weight (Monoisotopic): 390.1362AlogP: 2.33#Rotatable Bonds: 7
Polar Surface Area: 117.26Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.90CX Basic pKa: 5.60CX LogP: 2.39CX LogD: 2.38
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.57

References

1. Moslin R, Zhang Y, Wrobleski ST, Lin S, Mertzman M, Spergel S, Tokarski JS, Strnad J, Gillooly K, McIntyre KW, Zupa-Fernandez A, Cheng L, Sun H, Chaudhry C, Huang C, D'Arienzo C, Heimrich E, Yang X, Muckelbauer JK, Chang C, Tredup J, Mulligan D, Xie D, Aranibar N, Chiney M, Burke JR, Lombardo L, Carter PH, Weinstein DS..  (2019)  Identification of N-Methyl Nicotinamide and N-Methyl Pyridazine-3-Carboxamide Pseudokinase Domain Ligands as Highly Selective Allosteric Inhibitors of Tyrosine Kinase 2 (TYK2).,  62  (20): [PMID:31314518] [10.1021/acs.jmedchem.9b00443]

Source